Patents Assigned to Biond Biologies Ltd.
  • Antibodies against ILT2
    Patent number: 11236162
    Abstract: The present invention provides monoclonal antibodies, or antigen-binding portions thereof, against ILT2, as well as pharmaceutical compositions comprising same and methods of producing same. Also provided are methods of treating cancer comprising administering the antibodies or compositions of the invention. Methods of treating cancer, combination treatments, and patient selection are also provided.
    Type: Grant
    Filed: April 6, 2021
    Date of Patent: February 1, 2022
    Assignee: Biond Biologies Ltd.
    Inventors: Ilana Mandel, Tsuri Peretz, Dana Haves Ziv, Ilana Goldshtein, Dror Alishekevitz, Anna Fridman-Dror, Motti Hakim, Avidor Shulman, Yair Sapir, Tehila Ben-Moshe